Literature DB >> 23284080

HIV pathogenesis: dynamics and genetics of viral populations and infected cells.

John Coffin1, Ronald Swanstrom.   

Abstract

In the absence of treatment, HIV-1 infection, usually starting with a single virion, leads inexorably to a catastrophic decline in the numbers of CD4(+) T cells and to AIDS, characterized by numerous opportunistic infections as well as other symptoms, including dementia and wasting. In the 30 years since the AIDS pandemic came to our attention, we have learned a remarkable amount about HIV-1, the responsible virus--the molecular details about how it functions and interacts with the host cell, its evolution within the host, and the countermeasures it has evolved to overcome host defenses against viral infection. Despite these advances, we remain remarkably ignorant about how HIV-1 infection leads to disease and the death of the human host. In this brief article, we introduce and discuss important lessons that we have learned by examining the dynamics of viral populations and infected cells. These studies have revealed important features of the virus-host interaction that now form the basis of our understanding of the importance and consequence of ongoing viral replication during HIV-1 infection.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23284080      PMCID: PMC3530041          DOI: 10.1101/cshperspect.a012526

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Med        ISSN: 2157-1422            Impact factor:   6.915


  52 in total

Review 1.  Two long terminal repeat circles and persistent HIV-1 replication.

Authors:  M E Sharkey; M Stevenson
Journal:  Curr Opin Infect Dis       Date:  2001-02       Impact factor: 4.915

2.  HIV rebounds from latently infected cells, rather than from continuing low-level replication.

Authors:  Beda Joos; Marek Fischer; Herbert Kuster; Satish K Pillai; Joseph K Wong; Jürg Böni; Bernard Hirschel; Rainer Weber; Alexandra Trkola; Huldrych F Günthard
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-20       Impact factor: 11.205

3.  Control of viremia in simian immunodeficiency virus infection by CD8+ lymphocytes.

Authors:  J E Schmitz; M J Kuroda; S Santra; V G Sasseville; M A Simon; M A Lifton; P Racz; K Tenner-Racz; M Dalesandro; B J Scallon; J Ghrayeb; M A Forman; D C Montefiori; E P Rieber; N L Letvin; K A Reimann
Journal:  Science       Date:  1999-02-05       Impact factor: 47.728

4.  HIV-1 pathogenesis: the virus.

Authors:  Ronald Swanstrom; John Coffin
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

5.  HIV-1 replication and immune dynamics are affected by raltegravir intensification of HAART-suppressed subjects.

Authors:  Maria J Buzón; Marta Massanella; Josep M Llibre; Anna Esteve; Viktor Dahl; Maria C Puertas; Josep M Gatell; Pere Domingo; Roger Paredes; Mark Sharkey; Sarah Palmer; Mario Stevenson; Bonaventura Clotet; Julià Blanco; Javier Martinez-Picado
Journal:  Nat Med       Date:  2010-03-14       Impact factor: 53.440

6.  Effect of a protease inhibitor-induced genetic bottleneck on human immunodeficiency virus type 1 env gene populations.

Authors:  Kathryn M Kitrinos; Julie A E Nelson; Wolfgang Resch; Ronald Swanstrom
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

7.  Progress and Emerging Challenges in Preventing Mother-to-Child Transmission.

Authors:  Matthew F Chersich; Glenda E Gray
Journal:  Curr Infect Dis Rep       Date:  2005-09       Impact factor: 3.725

8.  Lower in vivo mutation rate of human immunodeficiency virus type 1 than that predicted from the fidelity of purified reverse transcriptase.

Authors:  L M Mansky; H M Temin
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

9.  CD8+ lymphocytes control viral replication in SIVmac239-infected rhesus macaques without decreasing the lifespan of productively infected cells.

Authors:  Nichole R Klatt; Emi Shudo; Alex M Ortiz; Jessica C Engram; Mirko Paiardini; Benton Lawson; Michael D Miller; James Else; Ivona Pandrea; Jacob D Estes; Cristian Apetrei; Joern E Schmitz; Ruy M Ribeiro; Alan S Perelson; Guido Silvestri
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

10.  In vivo CD8+ T-cell suppression of siv viremia is not mediated by CTL clearance of productively infected cells.

Authors:  Joseph K Wong; Matthew C Strain; Rodin Porrata; Elizabeth Reay; Sumathi Sankaran-Walters; Caroline C Ignacio; Theresa Russell; Satish K Pillai; David J Looney; Satya Dandekar
Journal:  PLoS Pathog       Date:  2010-01-29       Impact factor: 6.823

View more
  42 in total

1.  Nautilus: a bioinformatics package for the analysis of HIV type 1 targeted deep sequencing data.

Authors:  Gustavo H Kijak; Phuc Pham; Eric Sanders-Buell; Elizabeth A Harbolick; Leigh Anne Eller; Merlin L Robb; Nelson L Michael; Jerome H Kim; Sodsai Tovanabutra
Journal:  AIDS Res Hum Retroviruses       Date:  2013-08-02       Impact factor: 2.205

2.  A hardwired HIV latency program.

Authors:  Brandon S Razooky; Anand Pai; Katherine Aull; Igor M Rouzine; Leor S Weinberger
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

Review 3.  Fate-Regulating Circuits in Viruses: From Discovery to New Therapy Targets.

Authors:  Anand Pai; Leor S Weinberger
Journal:  Annu Rev Virol       Date:  2017-08-11       Impact factor: 10.431

4.  Immune Control of HIV.

Authors:  Muthukumar Balasubramaniam; Jui Pandhare; Chandravanu Dash
Journal:  J Life Sci (Westlake Village)       Date:  2019-06

5.  HIV-1 pathogenesis: the virus.

Authors:  Ronald Swanstrom; John Coffin
Journal:  Cold Spring Harb Perspect Med       Date:  2012-12-01       Impact factor: 6.915

6.  GRL-079, a Novel HIV-1 Protease Inhibitor, Is Extremely Potent against Multidrug-Resistant HIV-1 Variants and Has a High Genetic Barrier against the Emergence of Resistant Variants.

Authors:  Nicole S Delino; Manabu Aoki; Hironori Hayashi; Shin-Ichiro Hattori; Simon B Chang; Yuki Takamatsu; Cuthbert D Martyr; Debananda Das; Arun K Ghosh; Hiroaki Mitsuya
Journal:  Antimicrob Agents Chemother       Date:  2018-04-26       Impact factor: 5.191

7.  Targeted deep sequencing of HIV-1 using the IonTorrentPGM platform.

Authors:  Gustavo H Kijak; Eric Sanders-Buell; Elizabeth A Harbolick; Phuc Pham; Agnes L Chenine; Leigh Anne Eller; Kathleen Rono; Merlin L Robb; Nelson L Michael; Jerome H Kim; Sodsai Tovanabutra
Journal:  J Virol Methods       Date:  2014-05-04       Impact factor: 2.014

8.  HIV latency. Specific HIV integration sites are linked to clonal expansion and persistence of infected cells.

Authors:  F Maldarelli; X Wu; L Su; F R Simonetti; W Shao; S Hill; J Spindler; A L Ferris; J W Mellors; M F Kearney; J M Coffin; S H Hughes
Journal:  Science       Date:  2014-06-26       Impact factor: 47.728

9.  Competitive exclusion by autologous antibodies can prevent broad HIV-1 antibodies from arising.

Authors:  Shishi Luo; Alan S Perelson
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-31       Impact factor: 11.205

Review 10.  Improving Viral Protease Inhibitors to Counter Drug Resistance.

Authors:  Nese Kurt Yilmaz; Ronald Swanstrom; Celia A Schiffer
Journal:  Trends Microbiol       Date:  2016-04-15       Impact factor: 17.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.